Učitavanje...
New Therapies in Head and Neck Cancer
Head and neck squamous cell carcinoma (HNSCC) is a common malignancy with high rates of mortality and morbidity. Beginning with cetuximab, investigators continue to optimize antibody technology to target cell surface receptors that promote HNSCC growth. Small molecules and oligonucleotides have also...
Spremljeno u:
| Izdano u: | Trends Cancer |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6226306/ https://ncbi.nlm.nih.gov/pubmed/29709262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2018.03.006 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|